Summary
Increased formation of hydroxyl free radicals (·OH) reflected by ·OH adduct of salicylate in brain dialysate was demonstrated during the sustained (more than 2 hours) dopamine overflow elicited by 75 nmol of 1-methyl-4-phenyldihydropyridine (MPDP+) and 1-methyl-4-phenylpyridinium (MPP+) in the rat striatum. Owing to its weak dopamine releasing action, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) did not significantly increase the ·OH formation. This data suggests that sustained elevation of dopamine in the extracellular fluid elicited by MPTP analogues can be auto-oxidized, which in turn leads (possibly by indirect mechanisms) to the formation of cytotoxic ·OH free radicals near the nigrostriatal terminals.
Similar content being viewed by others
References
Ben-Shachar D, Riederer P, Youdim MBH (1991) Iron-melanin interaction and lipid peroxidation: implications for Parkinson's disease. J Neurochem 57: 1609–1614
Carlsson A, Winblad B (1976) Influence of age and time intervals between death and autopsy on dopamine and 3-methoxytyramine levels in human basal ganglia. J Neural Transm 38: 271–276
Chiueh CC, Huang S-J (1991) MPP+: a novel voltage-regulated ion channel activator for dihydropyridine-sensitive L-type calcium channels on nigrostriatal dopaminergic terminals. Posters Neurosci 1: 37–41
Chiueh CC, Zukowska-Grojex Z, Kirk KL, Kopin IJ (1983) 6-Fluorocatecholamines as false adrenergic neurotransmitters. J Pharmacol Exp Ther 225: 529–533
Chiueh CC, Huang S-J, Murphy DL (1992) Enhanced hydroxyl radical generation by 2′-methyl analog of MPTP: suppression by clorgyline and deprenyl. Synapse (in press)
Cleeter MWJ, Cooper JM, Schapira AHV (1992) Irreversible inhibition of mitochondrial complex I by 1-methyl-4-phenylpyridinium: evidence for free radical involvement. J Neurochem 58: 786–789
Cohen G (1988) Oxygen radicals and Parkinson's disease. In: Halliwell B (ed) Oxygen radicals and tissue injury. FASEB, Bethesda, pp 130–135
Dexter DT, Carter CJ, Wells FR, Javoy-Agid F, Agid Y, Lees A, Jenner P, Marsden CD (1989) Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. J Neurochem 52: 381–389
Donaldson J, LaBella FS, Gesser D (1981) Enhanced autoxidation of dopamine as a possible basis of manganese neurotoxicity. Neurotoxicology 2: 53–64
Floyd RA, Watson J, Wong PK (1984) Sensitive assay of hydroxyl free radical formation utilizing high pressure liquid chromatography with electrochemical detection of phenol and salicylate hydroxylation products. J Biochem Biophys Methods 10: 221–235
Fornstedt B, Brun A, Rosengren E, Carlsson A (1989) The apparent autoxidation rate of catechols in dopamine-rich regions of human brains increases with the degree of depigmentation of substantia nigra. J Neural Transm [P-DSect] 1: 279–295
Fornstedt B, Pileblad E, Carlsson A (1990) In vivo autoxidation of dopamine in guinea pig striatum increases with age. J Neurochem 55: 655–659
Graham DG (1984) Catecholamine toxicity: a proposal for the molecular pathogenesis of manganese neurotoxicity and Parkinson's disease. Neurotoxicology 5: 83–96
Hallgren B, Sourander P (1958) The effect of age on the non-haemin iron in the human brain. J Neurochem 3: 41–51
Halliwell B (1989) Oxidants and the central nervous system: some fundamental questions, is oxidant damage relevant to Parkinson's disease, Alzheimer's disease, traumatic injury, or stroke? Acta Neurol Scand 126: 23–33
Halliwell B, Kaur H, Ingleman-Sundberg M (1991) Hydroxylation of salicylate as an assay for hydroxyl radicals: a cautionary note. Free Radic Biol Med 10: 439–441
Hasegawa E, Takeshige K, Oishi T, Yoshiyuki M, Shigeki M (1990) MPP+ induces NADH-dependent superoxide formation and enhances NADH-dependent lipid peroxidation in bovine heart submitochondrial particles. Biochem Biophys Res Commun 170: 1049–1055
Heikkila RE, Kindt MV, Sonsalla PK, Giovanni A, Youngster SK, McKeown KA, Singer TP (1988) Importance of monoamine oxidase A in the bioactivation of neurotoxic analogues of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Proc Natl Acad Sci USA 85: 6172–6176
Hill JM (1990) Iron and proteins of iron metabolism in the central nervous system. In: Ponka P, Schulman HM, Woodworth RC (eds) Iron transport and storage. CRC Press, Boston, pp 315–330
Hirsch E, Graybiel AM, Agid YA (1988) Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease. Nature (Lond) 334: 345–348
Hirsch EC, Brandel J-P, Galle P, Javoy-Agid F, Agid Y (1991) Iron and aluminium increase in the substantia nigra of patients with Parkinson's disease: an X-ray microanalysis. J Neurochem 56: 446–451
Jenner P, Dexter DT, Schapira AHV, Marsden CD (1990) Free radical involvement and altered iron metabolism as a cause of Parkinson's disease. In: Marsden CD, Fahn S (eds) The assessment of therapy of parkinsonism. Parthenon, New Jersey, pp 17–30
Miyake H, Chiueh CC (1989) Effects of MPP+ on the release of serotonin and 5-hydroxyindoleacetic acid from rat striatum in vivo. Eur J Pharmacol 166: 49–55
Moore KE, Chiueh CC, Zeldes G (1976) Release of neurotransmitters from the brain in vivo by amphetamine, methylphenidate and cocaine. In: Ellinwood EH, Kilbey MM (eds) Cocaine and other stimulants. Plenum, New York, pp 143–160
Mytilineou C, Cohen G (1985) Deprenyl protects dopamine neurons from the neurotoxic effects of 1-methyl-4-phenylpyridinium ion. J Neurochem 45: 1951–1953
Paxinos G, Watson C (1982) The rat brain in stereotaxic coordinates. Academic Press, Sydney
Poirier J, Donaldson J, Barbeau A (1985) The specific vulnerability of the substantia nigra to MPTP is related to the presence of transition metals. Biochem Biophys Res Commun 128: 25–33
Reinhard JF Jr, Carmichael SW, Daniels AJ (1990) Mechanisms of toxicity and cellular resistance to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 1-methyl-4-phenylpyridinium in adrenomedullary chromaffin cell cultures. J Neurochem 55: 311–320
Riederer P, Sofic E, Rausch W-D, Schmidt B, Reynolds GP, Jellinger K, Youdim MBH (1989) Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains. J Neurochem 52: 515–520
Rollema H, Kuhr WH, Kranenborg G, De Vries J, Van Den Berg C (1988) MPP+-induced efflux of dopamine and lactate from rat striatum have similar time courses as shown by in vivo brain dialysis. J Pharmacol Exp Ther 245: 858–866
Rossetti ZL, Sotgiu A, Sharp DE, Hadjiconstantinou M, Neff NH (1988) 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and free radicals in vitro. Biochem Pharmacol 37: 4573–4574
Sanchez-Ramos JR, Barrett JN, Goldstein M, Weiner WF, Hefti F (1986) MPP+, but not MPTP, selectively detroys dopaminergic neurons in cultures of dissociated rat mesencephalic neurons. Neurosci Lett 72: 215–220
Sanchez-Ramos JR, Song S, Mash DC, Weiner WJ (1992) 21-Aminosteroids interact with dopamine transporter to protect against 1-methyl-4-phenylpyridinium-induced neurotoxicity. J Neurochem 58: 328–344
Sinha BK, Singh Y, Krishna G (1986) Formation of superoxide and hydroxyl radicals from 1-methyl-4-phenylpyridinium ion MPP+: reduction activation by NADPH cytochrome p-450 reductase. Biochem Biophys Res Commun 135: 283–288
Spina MB, Cohen G (1989) Dopamine turnover and glutathione oxidation: implications for Parkinson disease. Proc Natl Acad Sci USA 86: 1398–1400
Sun CJ, Johannessen JN, Gessner W, Namura I, Singhaniyom W, Brossi A, Chiueh CC (1988) Neurotoxic damage to the nigrostriatal system in rats following intranigral administration of MPDP+ and MPP+. J Neural Transm 74: 75–86
Youdim MBH, Ben-Shachar D, Riederer P (1989) Is Parkinson's disease a progressive siderosis of substantia nigra resulting in iron and melanin induced neurodegeneration? Acta Neurol Scand 126: 47–54
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Obata, T., Chiueh, C.C. In vivo trapping of hydroxyl free radicals in the striatum utilizing intracranial microdialysis perfusion of salicylate: effects of MPTP, MPDP+, and MPP+ . J. Neural Transmission 89, 139–145 (1992). https://doi.org/10.1007/BF01245361
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01245361